Arm Holdings CEO says AI will help cure cancer within our lifetimes

Key points

• Arm Holdings CEO Rene Haas said AI will help find a cure for cancer "within our lifetimes."
• Haas cited DNA marker modelling as a problem currently too complex for humans or computers, but one AI will eventually solve.
• Arm Holdings designs the chip blueprints used inside the vast majority of the world's smartphones and most AI hardware.
• Haas also predicted humanoid robots, physical machines that move and work like people, will see widespread use within five years.

The boss of one of Britain's most influential chip companies believes artificial intelligence will help humanity cure cancer. Rene Haas, chief executive of Arm Holdings, the Cambridge-based company whose chip designs power most of the world's smartphones and a growing share of AI hardware, made the claim in comments first reported by The Guardian.

His argument is specific. Figuring out how a DNA marker, a biological signal in the body that can indicate disease, changes when cancer strikes involves so many interacting variables that neither human researchers nor today's computers can fully process it. Haas says AI systems will eventually be powerful enough to map those interactions and point scientists toward treatments.

Is there any basis for the claim?

AI is already accelerating drug discovery, though a full cancer cure remains speculative. Google DeepMind's AlphaFold model, a system that predicts how proteins fold into their three-dimensional shapes, has already helped researchers understand disease mechanisms that stumped biologists for decades. Several pharmaceutical companies now use AI tools to screen millions of potential drug compounds in the time it once took to test a handful.

That said, predicting protein shapes is a well-defined problem with clear rules. Unravelling cancer across all its forms, each driven by different genetic faults and environmental factors, is a far messier challenge. Haas is expressing confidence in the direction of travel, not announcing a timeline backed by clinical data.

What about the robots?

Haas also said humanoid robots, machines built in roughly human shape that can move around and handle physical tasks, could become common within five years. That matches a broader industry bet: companies including Tesla, Figure AI and Boston Dynamics are all racing to build general-purpose robots that can work alongside people in warehouses and factories.

Arm has a commercial interest in both areas. Its chip architecture, the underlying blueprint that tells a processor how to handle instructions, sits inside many of the AI accelerators and edge devices that would power both smarter medical research tools and next-generation robots.

What does this mean for ordinary people?

For patients and families affected by cancer, the honest answer is: nothing immediate. Haas is talking about a trajectory, not a product launch. The encouraging signal is that serious computing executives, not just academic researchers, now treat the problem as solvable rather than intractable.

For workers, the robot prediction is worth watching. Five years is a short window. Industries that rely on repetitive physical labour, from logistics to manufacturing, may see significant changes in that timeframe, though widespread adoption depends on cost, regulation and how well the machines actually perform outside controlled demos.

Common questions

What is Arm Holdings and why does its CEO's opinion matter?

Arm Holdings designs the instruction sets, the basic rulebooks, that tell chips how to process information. Its blueprints are licensed to companies including Apple, Qualcomm and Nvidia, making Arm a central player in almost every device that runs AI today.

Has AI actually made progress on cancer research already?

Yes. AI tools have improved early detection in medical imaging, helped identify new drug targets and, through projects like AlphaFold, clarified how disease-linked proteins behave. A complete cure for all cancers remains a long-term goal, not an imminent one.

Should I expect humanoid robots in my workplace within five years?

Possibly in some industries. Warehouses and car plants are the most likely early settings. Wider deployment in offices, shops or hospitals would take longer and depend heavily on how safely and reliably the machines perform.